CoreAge Rx HRT review: estrogen options, progesterone and current availability

What the estrogen page now shows

The current estrogen page describes oral estradiol, a skin patch, gel and low-dose vaginal cream. It separates systemic treatment for hot flashes and night sweats from local treatment for vaginal symptoms. Those are useful distinctions, rather than a single hormone product presented as suitable for every concern.

We found the page through the treatment navigation and confirmed it loads publicly. The CoreAge estrogen-options guide explains the four listed routes. A product menu is a starting point for a medical assessment; it does not decide your prescription, identify every manufacturer or establish the approval status of the exact finished medicine.

The ordering process still needs confirmation

All four estrogen selections displayed a one-month plan at $0 during our browser check. Their visit buttons pointed to placeholder destinations rather than a configured intake. We do not interpret that display as free medication or evidence that a complete enrollment can currently be finished.

Use the linked product page to read the description, then confirm the current enrollment route and an itemized price directly with the service. We did not submit a medical intake, purchase anything or test pharmacy fulfillment. Our CoreAge cost guide separates public price displays from a usable treatment quote.

Oral progesterone is listed as coming soon

The progesterone page describes an oral micronized product, displays a starting price of $64.99 per month and labels the offer coming soon. It also describes the product as compounded. These details should travel together: the starting price does not prove that enrollment or dispensing is available today.

Systemic estrogen generally requires appropriate endometrial protection for someone with a uterus. Ask who will arrange the complete regimen if one advertised component is not available. Do not start estrogen while planning to sort out a needed second medicine later. The progesterone and estrogen guide explains the clinical role without prescribing a schedule.

Its nonhormonal page names a specific medicine

CoreAge’s nonhormonal page describes paroxetine 10 mg, with a $64.99 monthly starting display and a coming-soon notice. The page expressly describes menopause use as off-label. That is different from assuming the advertised product is Brisdelle, the FDA-approved 7.5 mg paroxetine capsule for moderate to severe menopausal hot flashes.

Nonhormonal does not mean suitable for every medical history. In particular, paroxetine needs careful review when someone uses tamoxifen. Our paroxetine guide discusses product identity, interactions and follow-up. We do not repeat broad marketing language as proof that this medicine treats vaginal tissue changes or replaces systemic estrogen’s bone effects.

Thyroid care and men's TRT are separate services

The thyroid page describes levothyroxine and liothyronine for selected thyroid-treatment needs. It is not an alternative way to treat every symptom attributed to menopause. Its public selector also showed a zero-price plan and an unfinished order destination during our check, so a current prescription pathway and charge remain to be confirmed.

The injectable TRT page addresses men with low testosterone and also says coming soon. It does not establish a testosterone program for menopausal women. If you already take thyroid medicine, our HRT and thyroid-medication guide explains why the clinicians should coordinate changes rather than treating a broad hormone catalog as one interchangeable set of products.

Read the payment policy before committing

Product pages advertise no membership fee and standard delivery. The general policy nevertheless allows subscriptions with automatic renewals, depending on the selected plan. Having no separate membership charge does not establish that a medication purchase is a one-time payment.

The refund policy says an applicable consultation fee of $50–$100 can be nonrefundable once medical review starts, including when treatment is declined. It makes prescription orders final after approval and transmission to the pharmacy, potentially before shipment. It also states a 30-day cutoff from purchase, including delays while patient documents are missing, except where law requires otherwise. Confirm how those terms apply to the specific hormone plan before paying.

Ask who provides each part of care

The site identifies separate professional medical entities for clinical decisions and describes CoreAge Rx as the technology and administrative platform. Ask for the treating clinician, the actual dispensing pharmacy, the product label and the contact route for treatment questions. General statements about licensed pharmacies do not identify the pharmacy for an individual prescription.

Customer-service availability should also be distinguished from a guaranteed response by a prescriber. Find out what happens with a delayed refill, a side effect, unexpected bleeding or a concern that needs an examination. A website chat and a clinical follow-up plan have different jobs.

How to use this updated review

The earlier blanket statement that no menopause-related products were found is no longer accurate. There are now specific public pages to read and link to. Our remaining questions concern operational access, the final quote, product identity and individual eligibility, rather than whether an estrogen page exists.

Read CoreAge versus Winona, CoreAge versus Alloy or CoreAge versus Midi for different care and billing models. First position on HRTMommy remains disclosed promotion, not evidence of superior medical outcomes. A clear, complete plan matters more than which provider appears first.